The tumor-promoting effects of ILK, in part, is attributable to its ability to phosphorylate Ser473-Akt and GSK3β [17], as well as to induce the expression of the oncogenic transcription/translation factor Y-box binding protein 1 (YB-1) [18, 19]. The gene discussed is YBX1; the disease is neoplasm.